FDA expedited access pathway enables staged approval opportunity for baroreflex activation therapy for heart failure with reduced ejection fraction: the BeAT-HF trial
EUROPEAN JOURNAL OF HEART FAILURE（2016）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要